CAPTRUST Financial Advisors
PTCT icon

CAPTRUST Financial Advisors’s PTC Therapeutics PTCT Stock Holding History

CAPTRUST Financial Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$649K Buy
7,962
+4,228
+113% +$305K ﹤0.01% 2001
2026
Q1 		$254K Buy
3,734
+260
+7% +$18.4K ﹤0.01% 2507
2025
Q4 		$264K Buy
+3,474
New +$252K ﹤0.01% 2340
2023
Q2 		– Sell
-5,286
Closed -$256K – 2579
2023
Q1 		$256K Buy
+5,286
New +$242K ﹤0.01% 1866
2022
Q3 		– Sell
-112
Closed -$4K – 3549
2022
Q2 		$4K Sell
112
-67
-37% -$2.35K ﹤0.01% 4207
2022
Q1 		$7K Sell
179
-268
-60% -$10.3K ﹤0.01% 3988
2021
Q4 		$18K Sell
447
-44
-9% -$1.68K ﹤0.01% 3365
2021
Q3 		$18K Buy
491
+80
+19% +$3.29K ﹤0.01% 3239
2021
Q2 		$17K Buy
411
+1
+0.2% +$43 ﹤0.01% 3224
2021
Q1 		$19K Buy
410
+365
+811% +$21.7K ﹤0.01% 3039
2020
Q4 		$3K Hold
45
– – ﹤0.01% 3023
2020
Q3 		$2K Hold
45
– – ﹤0.01% 2797
2020
Q2 		$2K Buy
+45
New +$2.21K ﹤0.01% 2625
2019
Q4 		– Sell
-110
Closed -$4K – 1598
2019
Q3 		$4K Buy
+110
New +$4.79K ﹤0.01% 1692

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

CAPTRUST Financial Advisors's PTCT Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its PTC Therapeutics (PTCT) stake by 113% in Q2 2026, buying an estimated $305K and bringing the position to 7,962 shares worth $649K. The position accounts for ﹤0.01% of the portfolio, ranked #2001.

CAPTRUST Financial Advisors first reported a position in PTCT in Q3 2019 and has held it in 14 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • CAPTRUST Financial Advisors held 7,962 shares of PTC Therapeutics worth $649K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 4,228 PTC Therapeutics shares in Q2 2026, an estimated $305K.
  • PTC Therapeutics made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2001 holding.
  • CAPTRUST Financial Advisors first reported a position in PTC Therapeutics in Q3 2019 and has held it in 14 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.